Liver Mets (Metastases) ICD-10-CM Codes
Discover the ICD-10-CM codes for diagnosing and documenting secondary liver tumors or metastases—a crucial coding guide for oncological conditions.
Fact Checked by Nate Lacson.
%20(1).png)
What ICD-10 Codes are Used for Liver Metastases
Liver metastases refer to cancerous tumors that have spread to the liver from another part of the body. These metastases are not the same as primary liver cancers originating in the liver. The ICD-10-CM system offers specific codes for secondary liver tumors or metastases.
Here's the primary ICD-10-CM code for liver metastases:
C78.7: Secondary malignant neoplasm of liver and intrahepatic bile duct
Clinical Description: This code describes tumors metastasizing to the liver from other primary cancer sites.
Which Liver Mets ICD Codes are Billable:
- C78.7: Yes
Clinical Information
- Liver metastases are more common than primary liver cancer and often originate from colorectal, breast, lung, pancreas, and stomach cancers.
- The presence of liver mets usually indicates advanced-stage cancer.
- Symptoms might include jaundice, abdominal pain, unexplained weight loss, fatigue, and loss of appetite.
- Imaging tests like CT, MRI, and ultrasound are often used for detection.
- Management options include surgery, chemotherapy, radiation, targeted therapy, and other advanced interventional techniques.
- The prognosis largely depends on the primary cancer type, the extent of liver involvement, and the patient's overall health.
Synonyms Include
- Metastatic tumors in the liver
- Secondary liver cancer
- Hepatic metastasis
- Liver secondary neoplasms
.png)
Commonly asked questions
A Liver Mets ICD-10-CM code should be used in medical documentation when a patient has been diagnosed with cancer that has metastasized to the liver from another primary site.
Liver metastases are usually detected through imaging tests such as CT scans, MRIs, or ultrasounds. Blood tests and biopsy may also be used for confirmation.
A diagnosis code for liver metastases provides a standardized way to indicate that a patient has secondary liver tumors originating from another cancerous site. This coding facilitates clinical care, research, and administrative activities like insurance billing.
